PETER LOUIS GEHLBACH
Affiliation: Johns Hopkins University
- PPAR-alpha Ligands as Potential Therapeutic Agents for Wet Age-Related Macular DegenerationMarisol del V Cano
The Wilmer Ophthalmological Institute, School of Medicine, Johns Hopkins University, Baltimore, MD 21287 9278, USA
PPAR Res 2008:821592. 2008..This review examines current literature for potential roles of PPAR-alpha in the pathogenesis and potential treatment of AMD with emphasis on prevention and treatment of wet AMD...
- Statins for age-related macular degenerationPeter Gehlbach
Retina Division, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Cochrane Database Syst Rev 3:CD006927. 2012..Recent epidemiologic, genetic and pathological evidence has shown AMD shares a number of risk factors with atherosclerosis, leading to the hypothesis that statins may exert protective effects in AMD...
- Treatment of Ocular Neovascularization by InhibitorsPeter Gehlbach; Fiscal Year: 2005..It will also provide me with clinical training to eventually translate the knowledge into new treatments for patients. ..